Nephrotic syndrome in children: risk factors for steroid dependence.

##plugins.themes.academic_pro.article.sidebar##

Published Dec 7, 2016
Download
pdf
Vol. 94 No. 7 (2016): Issue Jul 2016

##plugins.themes.academic_pro.article.main##

Manel Jellouli
Meriem Brika
Kamel Abidi
Meriem Ferjani
Ouns Naija
Yousra Hammi
Tahar Gargah

Abstract

 Background :
Most patients with idiopathic nephrotic syndrome are steroid-responsive, about 50% relapse and often become steroid-dependent and exposed to long-term steroid complications. The aim of this study was to determine predictive risk factors for steroid dependence using clinical and biological variables present at onset of the disease. It may be useful to adapt the therapeutic strategy.
Methods: Retrospective hospital-based cohort study in the department of pediatric nephrology of Charles Nicolle, Tunis, between 2002 and 2012 included 52 children with idiopathic steroid-responsive nephrotic.
Results: Risk factors for steroid dependency identified from univariate analysis were season of the first episode (winter or autumn) (p=0.008), hyperalpha2globulinemia>16g/l (p=0.028), hyperbeta2globulinemia >3g/l (p=0.003), hypercholesterolemia>10mmol/l (p=0.001), proteinuria>110mg/kg/day (p=0.05), time to achieve remission>9 days (p=0,0001). Logistic regression revealed that time to first remission and hypercholesterolemia>10mmol/l at first presentation were independent risk factors for steroid dependency.
Conclusion : Time to first remission, hypercholesterolemia more than 10mmol/l at first presentation and a respiratory tract infection at first relapse are independent risk factors for steroid dependency.

Keywords:

Nephrotic syndrome, Child, Corticosteroid, Risk factors

##plugins.themes.academic_pro.article.details##

References

  1. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet 2003; 362:629-39.
  2. Bagga A, Mantan M. Nephrotic syndrome in children. Indian J Med Res 2005;122:13-28.
  3. Niaudet P, Boyer O. Idiopathic nephrotic syndrome in childhood : clinical aspects. Pediatr Nephrol 2009: 667-702.
  4. Deschênes G, Leclerc A. Epidémiologie du syndrome néphrotique de l'enfant. Arch Pediatr 2010;17:622-3.
  5. Schachter AD. The pediatric nephrotic syndrome spectrum: clini¬cal homogeneity and molecular heterogeneity. Pediatr Transplant 2004; 8:344-8.
  6. Vivarelli M. Time for initial response to steroids is a major prognostic factor in idiopathic nephrotic syndrome. J Pediatr 2010; 156:965-71.
  7. Nakanishi K. Two-year outcome of the ISKDC regimen and frequent-relapsing risk in children with idiopathic nephrotic syndrome. Clin J Am Soc Nephrol 2013;8:756-62.
  8. Wong W. Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study. J Pediatr Child Health 2007; 43:337-41.
  9. Harambat J. Prediction of steroid-sparing agent use in childhood idiopathic nephrotic syndrome. Pediatr Nephrol 2013; 28:631-8.
  10. Bérard E, Broyer M, Dehennault M et al. Syndrome néphrotique pur (ou néphrose) corticosensible de l'enfant : Protocole de traitement proposé par la Société de Néphrologie Pédiatrique. Nephrol Ther 2005;1:150-6.
  11. Letavernier B, Letavernier E, Leroy S et al. Prediction of high-degree steroid dependency in pediatric idiopathic nephrotic syndrome. Pediatr Nephrol 2008; 23:2221-6.
  12. Fujinaga S, Hirano D, Nishizaki N. Early identification of steroid dependency in Japanese children with steroid-sensitive nephrotic syndrome undergoing short-term initial steroid therapy. Pediatr Nephrol 2011; 26:485-6.
  13. Rüth EM, Kemper MJ, Leumann EP et al. Children with steroid sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr 2005;147:202-7.
  14. Sarker MN, Islam MMSU, Saad T et al. Risk factor for relapse in childhood nephrotic syndrome - a hospital based retrospective study. Med Coll J 2012;7:18-22.
  15. Al Salloum A, Muthanna A, Bassrawi R et al. Long-term outcome of the difficult nephrotic syndrome in children. Saudi J Kidney Dis Transpl 2012; 23:965-72.
  16. Lin CY, Lee BH, Lin CC et al. A study of the relationship between childhood nephrotic syndrome and allergic diseases. Chest 1990; 97:1408-11.
  17. Noer MS. Predictors of relapse in steroid-sensitive nephrotic syndrome. Southeast Asian J Trop Med Public Health 2005; 36:1313-20.
  18. Sureshkumar P, Hodson EM, Willis NS et al. Predictors of remission and relapse in idiopathic nephrotic syndrome: a prospective cohort study. Pediatr Nephrol 2014; 29:1039-46.
  19. Anderson RF, Thrane N, Noergaard K et al. Early age at debut is a predictor of steroid-dependent and frequent relapsing nephrotic syndrome. Pediatr Nephrol 2010; 25:1299-304.
  20. Kabuki N, Okugawa T, Hayakawa H. Influence of age at onset on the outcome of steroid-sensitive nephrotic syndrome. Pediatr Nephrol 1998; 12:467-70.
  21. Yap HK, Han EJ, Heng CK et al. Risk factors for steroid dependency in children with idiopathic nephrotic syndrome. Pediatr Nephrol 2001; 16:1049-52.
  22. Rodriguez-Iturbe B, Herrera-Acosta J, Johnson RJ. Interstitial inflammation, sodium retention, and the pathogenesis of nephrotic edema: a unifying hypothesis. Kidney Int 2002; 62:1379-84.
  23. Takeda A, Takimoto H, Mizusawa Y et al. Prediction of subsequent relapse in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 2001;16:888-93.
  24. El-Melegy NT, Mohamed NA, Sayed MM. Oxidative modification of low-density lipoprotein in relation to dyslipidemia and oxidant status in children with steroid sensitive nephrotic syndrome. Pediatr Res 2008; 63:404-9.
  25. Ghodake SR, Suryakar AN, Ankush RD et al. Role of free radicals and antioxidant status in childhood nephrotic syndrome. Indian J Nephrol 2011; 21:37-40.
  26. Ehrich JH, Brodehl J. Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie. Eur J Pediatr 1993;152:357-61.
  27. MacHardy N, Miles PV, Massengill SF et al. Management patterns of childhood-onset nephrotic syndrome. Pediatr Nephrol 2009;24:2193-201.
  28. Hodson EM, Craig JC. Corticosteroid therapy for steroid-sensitive nephrotic syndrome in children: dose or duration? J Am Soc Nephrol 2013;24:7-9.
  29. Hiraoka M, Tsukahara H, Matsubara K et al. A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children. Am J Kidney Dis 2003;41:1155-62.